Mariam Zewail

759 total citations
32 papers, 576 citations indexed

About

Mariam Zewail is a scholar working on Pharmaceutical Science, Dermatology and Rheumatology. According to data from OpenAlex, Mariam Zewail has authored 32 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmaceutical Science, 9 papers in Dermatology and 8 papers in Rheumatology. Recurrent topics in Mariam Zewail's work include Advancements in Transdermal Drug Delivery (11 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and Toxin Mechanisms and Immunotoxins (6 papers). Mariam Zewail is often cited by papers focused on Advancements in Transdermal Drug Delivery (11 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and Toxin Mechanisms and Immunotoxins (6 papers). Mariam Zewail collaborates with scholars based in Egypt, Kuwait and United States. Mariam Zewail's co-authors include Haidy Abbas, Noha Nafee, Nabila Boraie, Maged W. Helmy, Nehal M. El‐Deeb, Passent M.E. Gaafar, Mohamed R. Mousa, Nesrine S. El Sayed, Laila Ahmed Rashed and Mohamed A. Khattab and has published in prestigious journals such as International Journal of Pharmaceutics, Journal of Pharmaceutical Sciences and Colloids and Surfaces B Biointerfaces.

In The Last Decade

Mariam Zewail

30 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mariam Zewail Egypt 14 222 131 103 91 80 32 576
Antonia Mancuso Italy 18 282 1.3× 193 1.5× 110 1.1× 81 0.9× 50 0.6× 39 739
Yingying Li China 15 245 1.1× 160 1.2× 61 0.6× 31 0.3× 84 1.1× 59 672
Chien‐Yu Hsiao Taiwan 17 73 0.3× 189 1.4× 106 1.0× 33 0.4× 77 1.0× 38 791
Sung Rae Kim South Korea 15 253 1.1× 164 1.3× 122 1.2× 56 0.6× 24 0.3× 29 573
Xiaojun Shi China 16 115 0.5× 297 2.3× 170 1.7× 27 0.3× 66 0.8× 40 947
Lixia Pei China 15 172 0.8× 311 2.4× 52 0.5× 17 0.2× 70 0.9× 27 691
Hyun Ji Lee South Korea 9 66 0.3× 125 1.0× 76 0.7× 58 0.6× 178 2.2× 22 764
Xiaomeng Tang China 18 230 1.0× 392 3.0× 196 1.9× 29 0.3× 108 1.4× 38 945
Houshang Nemati Iran 11 44 0.2× 140 1.1× 38 0.4× 29 0.3× 132 1.6× 30 421
Heba F. Mansour Egypt 14 238 1.1× 70 0.5× 47 0.5× 21 0.2× 30 0.4× 20 426

Countries citing papers authored by Mariam Zewail

Since Specialization
Citations

This map shows the geographic impact of Mariam Zewail's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariam Zewail with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariam Zewail more than expected).

Fields of papers citing papers by Mariam Zewail

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariam Zewail. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariam Zewail. The network helps show where Mariam Zewail may publish in the future.

Co-authorship network of co-authors of Mariam Zewail

This figure shows the co-authorship network connecting the top 25 collaborators of Mariam Zewail. A scholar is included among the top collaborators of Mariam Zewail based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariam Zewail. Mariam Zewail is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abd‐Alhaseeb, Mohammad M., et al.. (2025). Novel Nose-to-brain delivery of carbenoxolone via mucoadhesive solid lipid nanoparticles for Parkinson’s symptoms management: In vitro and in vivo evaluation in a rotenone-induced rat model. International Journal of Pharmaceutics. 670. 125197–125197. 5 indexed citations
2.
Gaafar, Passent M.E., et al.. (2025). L-carnosine-loaded hya-ascorposomes Attenuate UVB-induced skin Photoaging: Formulation, in vitro andin vivoevaluation. International Journal of Pharmaceutics. 681. 125895–125895. 2 indexed citations
3.
Essawy, Marwa M., et al.. (2025). Fisetin topical delivery via ascorbyl palmitate/hyaluronan-enhanced limosomes: a novel paradigm for preventing UVB-induced skin photoaging. Journal of drug targeting. 34(4). 659–679. 1 indexed citations
4.
Zewail, Mariam, et al.. (2025). L-Carnosine loaded chondroitin sulphate functionalized proposomes as an effective tool for transdermal rheumatoid arthritis management. Journal of drug targeting. 34(3). 424–439. 1 indexed citations
5.
Zewail, Mariam, et al.. (2025). Intradermal delivery of teriflunomide loaded emulsomes using hollow microneedles for effective minimally invasive psoriasis management. European Journal of Pharmaceutics and Biopharmaceutics. 210. 114692–114692. 2 indexed citations
6.
Zewail, Mariam, Passent M.E. Gaafar, Haidy Abbas, & Manal A Elsheikh. (2025). Innovative rheumatoid arthritis management using injection replacement approach via dual therapeutic effects of hyalurosomes-encapsulated luteolin and dexamethasone. Colloids and Surfaces B Biointerfaces. 249. 114497–114497. 11 indexed citations
7.
8.
Zewail, Mariam, Manal A Elsheikh, Haidy Abbas, & Passent M.E. Gaafar. (2025). Unveiling the synergistic impact of cocktail nanohyalurosomes encapsulating berberine and dexamethasone in managing rheumatoid arthritis: in-vitro evaluation and biological studies. Journal of Microencapsulation. 42(5). 503–518. 1 indexed citations
9.
10.
Zewail, Mariam, et al.. (2024). An insight into fisetin, the miraculous multifaceted flavonol: Paving the road for enhanced delivery through promising pharmaceutical nano-formulations. Journal of Drug Delivery Science and Technology. 101. 106292–106292. 4 indexed citations
11.
Abbas, Haidy, et al.. (2024). Melatonin hyalurosomes in collagen thermosensitive gel as a potential repurposing approach for rheumatoid arthritis management via the intra-articular route. International Journal of Pharmaceutics. 661. 124449–124449. 13 indexed citations
12.
Zewail, Mariam. (2024). Leflunomide nanocarriers: a new prospect of therapeutic applications. Journal of Microencapsulation. 41(8). 715–738. 2 indexed citations
13.
Abbas, Haidy, et al.. (2024). Hypericin emulsomes combined with hollow microneedles as a non-invasive photodynamic platform for rheumatoid arthritis treatment. International Journal of Pharmaceutics. 653. 123876–123876. 12 indexed citations
14.
Abbas, Haidy, et al.. (2023). Non-invasive management of rheumatoid arthritis using hollow microneedles as a tool for transdermal delivery of teriflunomide loaded solid lipid nanoparticles. International Journal of Pharmaceutics. 644. 123334–123334. 24 indexed citations
15.
16.
Zewail, Mariam, Nehal M. El‐Deeb, Mohamed R. Mousa, & Haidy Abbas. (2022). Hyaluronic acid coated teriflunomide (A771726) loaded lipid carriers for the oral management of rheumatoid arthritis. International Journal of Pharmaceutics. 623. 121939–121939. 28 indexed citations
17.
Zewail, Mariam, et al.. (2022). Lipidic cubic-phase leflunomide nanoparticles (cubosomes) as a potential tool for breast cancer management. Drug Delivery. 29(1). 1663–1674. 44 indexed citations
18.
19.
Zewail, Mariam, Noha Nafee, & Nabila Boraie. (2021). Intra-Articular Dual Drug Delivery for Synergistic Rheumatoid Arthritis Treatment. Journal of Pharmaceutical Sciences. 110(7). 2808–2822. 25 indexed citations
20.
Zewail, Mariam, Noha Nafee, Maged W. Helmy, & Nabila Boraie. (2019). Coated nanostructured lipid carriers targeting the joints – An effective and safe approach for the oral management of rheumatoid arthritis. International Journal of Pharmaceutics. 567. 118447–118447. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonia Mancuso Breakdown of academic impact, for papers by Yingying Li Breakdown of academic impact, for papers by Chien‐Yu Hsiao Breakdown of academic impact, for papers by Sung Rae Kim Breakdown of academic impact, for papers by Xiaojun Shi Breakdown of academic impact, for papers by Lixia Pei Breakdown of academic impact, for papers by Hyun Ji Lee Breakdown of academic impact, for papers by Xiaomeng Tang Breakdown of academic impact, for papers by Houshang Nemati Breakdown of academic impact, for papers by Heba F. Mansour
Rankless by CCL
2026